Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:48 PM UTC
| NCT Number | NCT07424404 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE3 |
| Target Enrollment | 400 participants |
| Active Locations | 51 sites in the US |
| Sponsor | Karuna Therapeutics, Inc., a Bristol Myers Squibb company |
| Last Updated on CT.gov | August 28, 2026 (23 hours ago) |
As of August 28, 2026: Clinical trial NCT07424404 is currently recruiting participants. This phase3 study for schizophrenia is actively seeking new participants at 51 locations across the United States. The study is sponsored by Karuna Therapeutics, Inc., a Bristol Myers Squibb company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07424404 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07424404 was last updated 23 hours ago (August 28, 2026). HelloStudys verifies this status automatically.